Medical Management of Otosclerosis
dc.citation.issue | 2 | |
dc.citation.volume | v. 51 | |
dc.contributor.author | Penido, Norma de Oliveira [UNIFESP] | |
dc.contributor.author | Vicente, Andy de Oliveira | |
dc.coverage | Philadelphia | |
dc.date.accessioned | 2020-07-20T16:31:08Z | |
dc.date.available | 2020-07-20T16:31:08Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Otosclerosis/otospongiosis is a primary osteodystrophy of the otic capsule that affects genetically predisposed individuals and leads to progressive hearing loss. Diagnosis is usually clinical, based on the findings of anamnesis, physical examination, and audiometric evaluation. However, high-resolution computed tomography scan and MRI have played an important role in the diagnosis and therapeutic approach of otosclerosis and in assisting in the differential diagnosis. The therapeutic approach is aimed at preventing, or at least minimizing, disease progression while attempting to restore hearing. The use of sodium fluoride and bisphosphonates can be an important adjunct, perhaps even primary treatment, in managing active lesions. | en |
dc.description.affiliation | Univ Fed Sao Paulo, Escola Paulista Med, Dept Otorhinolaryngol Head & Neck Surg, Rua Mario Whateley 109-72, BR-05083140 Sao Paulo, SP, Brazil | |
dc.description.affiliation | Hosp Especializado CEMA, Otorhinolaryngol Dept, Rua Oratorio,1369 Mooca, BR-03117000 Sao Paulo, SP, Brazil | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Escola Paulista Med, Dept Otorhinolaryngol Head & Neck Surg, Rua Mario Whateley 109-72, BR-05083140 Sao Paulo, SP, Brazil | |
dc.description.source | Web of Science | |
dc.format.extent | 441-452 | |
dc.identifier | http://dx.doi.org/10.1016/j.otc.2017.11.006 | |
dc.identifier.citation | Otolaryngologic Clinics Of North America. Philadelphia, v. 51, n. 2, p. 441-452, 2018. | |
dc.identifier.doi | 10.1016/j.otc.2017.11.006 | |
dc.identifier.issn | 0030-6665 | |
dc.identifier.uri | https://repositorio.unifesp.br/handle/11600/55738 | |
dc.identifier.wos | WOS:000429182900015 | |
dc.language.iso | eng | |
dc.publisher | W B Saunders Co-Elsevier Inc | |
dc.relation.ispartof | Otolaryngologic Clinics Of North America | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Otosclerosis | en |
dc.subject | Otospongiosis | en |
dc.subject | Hearing loss | en |
dc.subject | Computed tomography | en |
dc.subject | MRI | en |
dc.subject | Sodium alendronate | en |
dc.subject | Sodium fluoride | en |
dc.title | Medical Management of Otosclerosis | en |
dc.type | info:eu-repo/semantics/article |